Speak directly to the analyst to clarify any post sales queries you may have.
The 5G-enabled medical devices market is transforming healthcare delivery by enabling faster, more reliable clinical connectivity. Senior decision-makers are using these innovations to optimize workflows, improve response times, and prepare their organizations for emerging opportunities in a changing digital landscape.
Market Snapshot: 5G-Enabled Medical Devices Market Size & Growth
The global 5G-enabled medical devices market is entering a phase of accelerated expansion, with an increase from USD 991.10 million in 2024 to USD 1.22 billion in 2025, reflecting a strong projected compound annual growth rate (CAGR) of 23.56% through 2032. By the end of this period, the market is estimated to reach USD 5.38 billion. Surging demand for real-time, dependable data streams is propelling adoption as healthcare organizations seek to digitize care delivery. Robust 5G infrastructure now forms the backbone of essential applications, ensuring seamless support for diagnostics, monitoring, and remote care. Investments in this technology are powering the modernization of clinical services across inpatient, outpatient, and home settings, with healthcare innovation increasingly driven by digital transformation.
Scope & Segmentation: 5G-Enabled Medical Devices Market
This report provides targeted analysis on how 5G adoption is guiding the evolution of medical devices, delivering strategic breakdowns that inform investment decisions across regions and technology categories. Segmentation is designed for clarity and practical application, enabling leaders to track trends and benchmark progress.
- Product Types: Diagnostic equipment, such as imaging platforms and point-of-care systems, facilitates early detection and efficient evaluation. Monitoring solutions—covering cardiac, glucose, and respiratory functions—deliver continuous oversight, while therapeutic devices, including infusion pumps and neurostimulators, offer enhanced precision for chronic and acute care.
- Applications: Uses span real-time asset tracking and emergency response optimization to remote patient management. The connectivity supports telemedicine platforms, boosts supply chain visibility, and implements smart hospital solutions, streamlining operations and extending care reach.
- End Users: Hospitals, clinics, ambulatory surgical centers, homecare organizations, and telehealth providers integrate 5G-enabled devices to advance operational efficiency and enhance patient engagement across diverse care environments.
- Connectivity Types: Key approaches include non-standalone and standalone 5G networks, private deployments, mmWave and sub-6 GHz options, each tailored to distinct performance, security, and scalability requirements.
- Network Architectures: The ecosystem encompasses hybrid deployments, enterprise solutions, and offerings from public operators or mobile virtual network operators (MVNOs), all designed for flexible, secure integration in medical settings.
- Components: Core hardware includes sensors, antennas, and modules. Services extend to consulting, integration, and ongoing maintenance, while software platforms handle analytics and device mobility management.
- Regions: Dynamics differ across the Americas, Europe, Asia-Pacific, and Middle East & Africa, shaped by deployment velocity, the availability of digital health infrastructure, and varying demands for connected medical technology.
- Company Coverage: Included analysis highlights established firms like General Electric Company, Siemens Healthineers AG, Koninklijke Philips N.V., Medtronic plc, Abbott Laboratories, and new entrants advancing medical device connectivity and system integration.
Key Takeaways for Senior Decision-Makers
- Integrating 5G with medical devices enables connected workflows that link diagnostics, monitoring, and operational systems, improving care coordination in both acute and distributed settings.
- Deploying private and hybrid 5G networks allows organizations to calibrate security protocols, supporting mission-critical applications and compliance with evolving regional health regulations.
- Adopting open standards and modular device architectures improves adaptability, helping organizations respond to regulatory changes and supply chain variability without major technology overhauls.
- Collaborations with telecommunications and analytics providers accelerate solution validation, supporting rapid scaling of telemedicine and management of chronic conditions.
- Tailoring adoption strategies to local infrastructure and reimbursement environments ensures that entry and expansion align with operational realities and long-term market potential.
- Granular segmentation enables targeted investment, allowing healthcare organizations to leverage connected health solutions in urgent response as well as ongoing chronic care management.
Tariff Impact: Navigating Cost Structures and Supply Chain Resilience
New and emerging tariffs in the United States have begun to affect sourcing and production costs for 5G-enabled medical devices. Manufacturers are strengthening ties with local suppliers, considering onshore and nearshore production, and using modular device designs to quickly adapt to changes. These strategies, supported by closer collaboration between device makers and telecommunications partners, reduce the risk of supply chain disruptions, helping organizations remain competitive in a complex trade landscape.
Methodology & Data Sources
This research leverages primary interviews with industry leaders, detailed consultations with subject matter experts, and secondary analysis of company reports and regulatory documents. Rigorous data triangulation ensures that insights are robust, actionable, and accurate to support critical decisions.
Why This Report Matters
- Equips executives to pinpoint and seize high-value growth opportunities that drive healthcare digital transformation and integrate 5G advances effectively.
- Empowers organizations to navigate regulatory adjustments and respond to the pace of technology adoption and global supply chain pressures through clear, actionable strategies.
- Delivers tailored, region-specific insights and guidance, helping leaders allocate resources strategically and maximize returns in both established and high-growth healthcare markets.
Conclusion
5G integration into medical devices is redefining the healthcare environment. Forward-looking leaders who engage these trends will drive organizational transformation and enhance patient outcomes in the evolving digital health landscape.
Additional Product Information:
- Purchase of this report includes 1 year online access with quarterly updates.
- This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.
Table of Contents
3. Executive Summary
4. Market Overview
7. Cumulative Impact of Artificial Intelligence 2025
Companies Mentioned
The companies profiled in this 5G-enabled Medical Devices market report include:- General Electric Company
- Siemens Healthineers AG
- Koninklijke Philips N.V.
- Medtronic plc
- Johnson & Johnson
- Abbott Laboratories
- Becton, Dickinson and Company
- Baxter International Inc.
- Boston Scientific Corporation
- Samsung Electronics Co., Ltd
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 192 |
| Published | October 2025 |
| Forecast Period | 2025 - 2032 |
| Estimated Market Value ( USD | $ 1.22 Billion |
| Forecasted Market Value ( USD | $ 5.38 Billion |
| Compound Annual Growth Rate | 23.5% |
| Regions Covered | Global |
| No. of Companies Mentioned | 11 |


